Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron P Mitchell

Showing results (141-150 of 206) with videos related to

Pageof 21
Sort By:
BMJ (Clinical Research Ed.)|October 25, 2023
Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort studyAaron P Mitchell, Stacie B Dusetzina, Akriti Mishra Meza, et al.
Genetics|May 14, 2021
Environmentally contingent control of Candida albicans cell wall integrity by transcriptional regulator Cup9Yuichi Ichikawa, Vincent M Bruno, Carol A Woolford, et al.
Journal of Oncology Practice|September 3, 2015
Clinical Trial Participants With Metastatic Renal Cell Carcinoma Differ From Patients Treated in Real-World PracticeAaron P Mitchell, Michael R Harrison, Mark S Walker, et al.
JAMA Oncology|January 4, 2019
Association Between Reimbursement Incentives and Physician Practice in Oncology: A Systematic ReviewAaron P Mitchell, Jason S Rotter, Esita Patel, et al.
Journal of the National Cancer Institute|October 1, 2021
Real-World Use of Bone-Modifying Agents in Metastatic Castration-Sensitive Prostate CancerAaron P Mitchell, Akriti Mishra Meza, Katherine S Panageas, et al.
Cellular Microbiology|August 31, 2006
Candida albicans protein kinase CK2 governs virulence during oropharyngeal candidiasisLisa Y Chiang, Donald C Sheppard, Vincent M Bruno, et al.
Antimicrobial Agents and Chemotherapy|June 13, 2012
Rapid redistribution of phosphatidylinositol-(4,5)-bisphosphate and septins during the Candida albicans response to caspofunginHassan Badrane, M Hong Nguyen, Jill R Blankenship, et al.
Journal of the National Cancer Institute|March 30, 2026
Use of Low-Value Cancer Care in Practices Acquired by Private Equity FirmsAaron P Mitchell, Miranda B Lam, Caroline Carlin, et al.
Infection and Immunity|December 24, 2014
Divergent targets of Aspergillus fumigatus AcuK and AcuM transcription factors during growth in vitro versus invasive diseaseMonsicha Pongpom, Hong Liu, Wenjie Xu, et al.
Microbiology Resource Announcements|June 22, 2019
Genome Sequence for Candida albicans Clinical Oral Isolate 529LChristina A Cuomo, Saranna Fanning, Sharvari Gujja, et al.
Pageof 21

Showing results (141-150 of 206) with videos related to

Sort By:
Pageof 21
BMJ (Clinical Research Ed.)|October 25, 2023
Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort studyAaron P Mitchell, Stacie B Dusetzina, Akriti Mishra Meza, et al.
Genetics|May 14, 2021
Environmentally contingent control of Candida albicans cell wall integrity by transcriptional regulator Cup9Yuichi Ichikawa, Vincent M Bruno, Carol A Woolford, et al.
Journal of Oncology Practice|September 3, 2015
Clinical Trial Participants With Metastatic Renal Cell Carcinoma Differ From Patients Treated in Real-World PracticeAaron P Mitchell, Michael R Harrison, Mark S Walker, et al.
JAMA Oncology|January 4, 2019
Association Between Reimbursement Incentives and Physician Practice in Oncology: A Systematic ReviewAaron P Mitchell, Jason S Rotter, Esita Patel, et al.
Journal of the National Cancer Institute|October 1, 2021
Real-World Use of Bone-Modifying Agents in Metastatic Castration-Sensitive Prostate CancerAaron P Mitchell, Akriti Mishra Meza, Katherine S Panageas, et al.
Cellular Microbiology|August 31, 2006
Candida albicans protein kinase CK2 governs virulence during oropharyngeal candidiasisLisa Y Chiang, Donald C Sheppard, Vincent M Bruno, et al.
Antimicrobial Agents and Chemotherapy|June 13, 2012
Rapid redistribution of phosphatidylinositol-(4,5)-bisphosphate and septins during the Candida albicans response to caspofunginHassan Badrane, M Hong Nguyen, Jill R Blankenship, et al.
Journal of the National Cancer Institute|March 30, 2026
Use of Low-Value Cancer Care in Practices Acquired by Private Equity FirmsAaron P Mitchell, Miranda B Lam, Caroline Carlin, et al.
Infection and Immunity|December 24, 2014
Divergent targets of Aspergillus fumigatus AcuK and AcuM transcription factors during growth in vitro versus invasive diseaseMonsicha Pongpom, Hong Liu, Wenjie Xu, et al.
Microbiology Resource Announcements|June 22, 2019
Genome Sequence for Candida albicans Clinical Oral Isolate 529LChristina A Cuomo, Saranna Fanning, Sharvari Gujja, et al.
Pageof 21